Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study

Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity‐Weighted Cohort Study

Background It is unclear whether nonvitamin K antagonist oral anticoagulants (NOACs) can mitigate dementia development in atrial fibrillation. We compared dementia development among users of NOACs or warfarin in patients with atrial fibrillation with no prior neurological diagnoses. Methods and Resu...

Full description

Bibliographic Details
Main Authors: Mette Søgaard, Flemming Skjøth, Martin Jensen, Jette Nordstrøm Kjældgaard, Gregory Y. H. Lip, Torben Bjerregaard Larsen, Peter Brønnum Nielsen
Format: Article
Language:English
Published: Wiley 2019-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulants
atrial fibrillation
dementia
direct oral anticoagulant
warfarin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.011358

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.011358

Similar Items